CN112514892A - 一种外泌体冻存保护液及其制备方法 - Google Patents
一种外泌体冻存保护液及其制备方法 Download PDFInfo
- Publication number
- CN112514892A CN112514892A CN202011560330.8A CN202011560330A CN112514892A CN 112514892 A CN112514892 A CN 112514892A CN 202011560330 A CN202011560330 A CN 202011560330A CN 112514892 A CN112514892 A CN 112514892A
- Authority
- CN
- China
- Prior art keywords
- exosome
- solution
- tris
- kcl
- cryopreservation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 90
- 238000005138 cryopreservation Methods 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title abstract description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 58
- 239000000243 solution Substances 0.000 claims abstract description 54
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 35
- 239000011780 sodium chloride Substances 0.000 claims abstract description 29
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000007853 buffer solution Substances 0.000 claims abstract description 24
- 239000001103 potassium chloride Substances 0.000 claims abstract description 19
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 12
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 12
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 9
- 239000008103 glucose Substances 0.000 claims abstract description 9
- 230000001681 protective effect Effects 0.000 claims abstract description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 17
- 239000012528 membrane Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 3
- 239000002577 cryoprotective agent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 230000004071 biological effect Effects 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000011164 potassium chloride Nutrition 0.000 description 16
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 210000000130 stem cell Anatomy 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000037816 tissue injury Diseases 0.000 description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 1
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011560330.8A CN112514892B (zh) | 2020-12-25 | 2020-12-25 | 一种外泌体冻存保护液及其制备方法 |
PCT/CN2021/094288 WO2022134434A1 (zh) | 2020-12-25 | 2021-05-18 | 一种外泌体冻存保护液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011560330.8A CN112514892B (zh) | 2020-12-25 | 2020-12-25 | 一种外泌体冻存保护液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112514892A true CN112514892A (zh) | 2021-03-19 |
CN112514892B CN112514892B (zh) | 2022-06-14 |
Family
ID=74976402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011560330.8A Active CN112514892B (zh) | 2020-12-25 | 2020-12-25 | 一种外泌体冻存保护液及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112514892B (zh) |
WO (1) | WO2022134434A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022134434A1 (zh) * | 2020-12-25 | 2022-06-30 | 广州赛莱拉干细胞科技股份有限公司 | 一种外泌体冻存保护液及其制备方法 |
CN114946830A (zh) * | 2022-04-26 | 2022-08-30 | 山东省齐鲁细胞治疗工程技术有限公司 | 一种基于响应面优化的细胞外囊泡的储存液及其制备方法 |
CN115885980A (zh) * | 2022-12-30 | 2023-04-04 | 唐颐控股(深圳)有限公司 | 一种外泌体冷藏保存保护液及应用 |
CN115990261A (zh) * | 2021-10-20 | 2023-04-21 | 谛邈生物科技(北京)有限公司 | 外泌体冻干粉针剂或外泌体液体制剂的保护剂 |
CN117598291A (zh) * | 2024-01-15 | 2024-02-27 | 北京恩康医药有限公司 | 一种外泌体保护液及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107312799A (zh) * | 2017-06-30 | 2017-11-03 | 深圳宾德生物技术有限公司 | 慢病毒载体冻存保护液及其制备方法和应用 |
CN108635372A (zh) * | 2018-05-17 | 2018-10-12 | 广东芙金干细胞再生医学有限公司 | 一种人间充质干细胞源外泌体的生物制剂的制备方法 |
US20190231694A1 (en) * | 2016-10-12 | 2019-08-01 | Agency For Science, Technology And Research | Method for lyophilising an exosome |
CN110840915A (zh) * | 2019-11-25 | 2020-02-28 | 深圳市第二人民医院 | 一种靶向间充质干细胞外泌体的制备方法及其应用 |
CN111226902A (zh) * | 2020-03-03 | 2020-06-05 | 中国科学院大学深圳医院(光明) | 一种外泌体保存液及外泌体的保存方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
US20140113273A1 (en) * | 2012-10-18 | 2014-04-24 | Lifeline Scientific, Inc. | Preservation of biomaterial properties and methods of storing |
CN106062205A (zh) * | 2013-12-20 | 2016-10-26 | 基本药品有限责任公司 | 细胞培养基 |
US10815456B2 (en) * | 2016-10-04 | 2020-10-27 | Transwell Biotech Co., Ltd. | Composition, kit and method for cryopreserving cells |
CN110913691A (zh) * | 2017-04-06 | 2020-03-24 | 北卡罗来纳大学教堂山分校 | 低温保存方法 |
CN108251361A (zh) * | 2018-04-19 | 2018-07-06 | 重庆斯德姆生物技术有限公司 | 一种脐带组织块冻存、复苏以及制备间充质干细胞的方法 |
CN108849858A (zh) * | 2018-07-26 | 2018-11-23 | 姚晓明 | 一种角膜中期保存液 |
CN111789104B (zh) * | 2019-04-09 | 2022-06-17 | 北京大学第三医院(北京大学第三临床医学院) | 一种冷冻保存液在干细胞冻存中的应用 |
JP2022528772A (ja) * | 2019-04-09 | 2022-06-15 | 北京大学第三医院(北京大学第三臨床医学院) | Dmsoフリーの凍結保存液及びその調製方法と応用 |
CN112080524A (zh) * | 2019-06-13 | 2020-12-15 | 南京艾德免疫治疗研究院有限公司 | 一种慢病毒载体冻存保护液的制备方法 |
CN111771874A (zh) * | 2020-08-05 | 2020-10-16 | 乔爱军 | 一种自体脂肪细胞冻存液及脂肪间充质干细胞等物质的冻存方法 |
CN112616829B (zh) * | 2020-12-21 | 2022-08-12 | 中科睿极(深圳)医学科技有限公司 | 间充质干细胞冻存液、间充质干细胞细胞库及制备方法 |
CN112514892B (zh) * | 2020-12-25 | 2022-06-14 | 广州赛莱拉干细胞科技股份有限公司 | 一种外泌体冻存保护液及其制备方法 |
-
2020
- 2020-12-25 CN CN202011560330.8A patent/CN112514892B/zh active Active
-
2021
- 2021-05-18 WO PCT/CN2021/094288 patent/WO2022134434A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190231694A1 (en) * | 2016-10-12 | 2019-08-01 | Agency For Science, Technology And Research | Method for lyophilising an exosome |
CN107312799A (zh) * | 2017-06-30 | 2017-11-03 | 深圳宾德生物技术有限公司 | 慢病毒载体冻存保护液及其制备方法和应用 |
CN108635372A (zh) * | 2018-05-17 | 2018-10-12 | 广东芙金干细胞再生医学有限公司 | 一种人间充质干细胞源外泌体的生物制剂的制备方法 |
CN110840915A (zh) * | 2019-11-25 | 2020-02-28 | 深圳市第二人民医院 | 一种靶向间充质干细胞外泌体的制备方法及其应用 |
CN111226902A (zh) * | 2020-03-03 | 2020-06-05 | 中国科学院大学深圳医院(光明) | 一种外泌体保存液及外泌体的保存方法 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022134434A1 (zh) * | 2020-12-25 | 2022-06-30 | 广州赛莱拉干细胞科技股份有限公司 | 一种外泌体冻存保护液及其制备方法 |
CN115990261A (zh) * | 2021-10-20 | 2023-04-21 | 谛邈生物科技(北京)有限公司 | 外泌体冻干粉针剂或外泌体液体制剂的保护剂 |
CN115990261B (zh) * | 2021-10-20 | 2024-01-05 | 光武惠文生物科技(北京)有限公司 | 外泌体冻干粉针剂或外泌体液体制剂的保护剂 |
CN114946830A (zh) * | 2022-04-26 | 2022-08-30 | 山东省齐鲁细胞治疗工程技术有限公司 | 一种基于响应面优化的细胞外囊泡的储存液及其制备方法 |
CN114946830B (zh) * | 2022-04-26 | 2023-08-29 | 山东省齐鲁细胞治疗工程技术有限公司 | 一种基于响应面优化的细胞外囊泡的储存液及其制备方法 |
CN115885980A (zh) * | 2022-12-30 | 2023-04-04 | 唐颐控股(深圳)有限公司 | 一种外泌体冷藏保存保护液及应用 |
CN117598291A (zh) * | 2024-01-15 | 2024-02-27 | 北京恩康医药有限公司 | 一种外泌体保护液及其应用 |
CN117598291B (zh) * | 2024-01-15 | 2024-04-09 | 北京恩康医药有限公司 | 一种外泌体保护液及其应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2022134434A1 (zh) | 2022-06-30 |
CN112514892B (zh) | 2022-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112514892B (zh) | 一种外泌体冻存保护液及其制备方法 | |
Cottle et al. | Impact of cryopreservation and freeze-thawing on therapeutic properties of mesenchymal stromal/stem cells and other common cellular therapeutics | |
CN108207930B (zh) | 一种鸡尾酒式冷冻保护剂及其应用 | |
CN106665560B (zh) | 一种直接静脉回输的免疫细胞冻存液及其应用 | |
Weng et al. | Dimethyl sulfoxide-free cryopreservation for cell therapy: A review | |
Zhang et al. | Cold-responsive nanoparticle enables intracellular delivery and rapid release of trehalose for organic-solvent-free cryopreservation | |
CN107148967B (zh) | 一种抗原特异性t淋巴细胞冻存液及其制备方法和应用 | |
RU2146088C1 (ru) | Концентрированный раствор для хранения в криогенных условиях (варианты), раствор для хранения в криогенных условиях, способ криогенного хранения клеток (варианты), способ криогенного хранения и регенерации жизнеспособных клеток, способ криогенного хранения, регенерации и терапевтического применения клеток | |
Yao et al. | Nanoparticle‐mediated intracellular protection of natural killer cells avoids cryoinjury and retains potent antitumor functions | |
CN110037010B (zh) | 一种温敏凝胶制剂及低温长期保存胰岛细胞的方法 | |
CN112841174A (zh) | 一种用于人脐带间充质干细胞长期保存的冻存液 | |
Stoll et al. | Membrane stability during biopreservation of blood cells | |
CN101919378A (zh) | 一种直接静脉应用的间充质干细胞冻存液 | |
CN112167240A (zh) | 临床级细胞冷藏保存液及其制备方法和应用 | |
CN113854280B (zh) | 一种低温保存液及其制备方法和应用 | |
CN112544611A (zh) | 细胞冻存剂及细胞的冻存方法 | |
CN105165805A (zh) | 无蛋白液氮细胞冻存液及其制备方法 | |
CN114984050A (zh) | 一种间充质干细胞外泌体冻干粉制备及使用方法 | |
EP1886559A2 (en) | Platelet additive solution | |
CN117084235A (zh) | 一种外泌体低温冻存保护液及其制备方法 | |
CN116270451A (zh) | 一种新鲜间充质干细胞注射液及其制备方法 | |
CN114009425B (zh) | 一种免疫细胞玻璃化冻存保护液及其冻存方法 | |
CN114190367B (zh) | 冻存液及其制备方法与在免疫细胞的应用 | |
US20230148586A1 (en) | Low-temperature storage of biological samples | |
CN115005199A (zh) | 一种自然杀伤细胞的冻存液、冻存方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 510300 unit 502, 5th floor, production area, No.1 helix 4 road, Guangzhou International Biological Island, Guangzhou Development Zone, Guangdong Province Applicant after: GUANGZHOU SALIAI STEM CELL SCIENCE AND TECHNOLOGY Co.,Ltd. Applicant after: Guangdong Guoke Cell Technology Co.,Ltd. Address before: 510000 unit 502, 5th floor, production area, No.1 helix 4th Road, Guangzhou International Biological Island, Shaoguan Development Zone, Guangdong Province Applicant before: GUANGZHOU SALIAI STEM CELL SCIENCE AND TECHNOLOGY Co.,Ltd. Applicant before: Guangdong Guoke Cell Technology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |